Perrigo shares swayed after the company reported quarterly results on Monday.
In the first quarter, the company saw a net loss of $2.34 per share on $1.34 billion in sales. Perrigo updated its loss figures shortly after it initially reported a net loss of 93 cents a share.
Analysts had expected earnings of 64 cents a share on $1.34 billion in sales, according to a consensus estimate from FactSet.
The stock opened lower on Tuesday before going positive. Shares of Perrigo were closed up 1.76 percent.
The pharmaceutical company also sees adjusted full-year earnings between $8.20 to $8.60 per share, which implies Perrigo forecasts an increase of 8 percent to 13 percent from its earnings of $7.59 a share in 2015.
Shares of Perrigo are down more than 53 percent in the last year.